These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 36714030)

  • 1. PLEKHA4 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma.
    Zhang W; Li L; Bian PP; Luo QP; Xiong ZT
    Biomed Res Int; 2023; 2023():4504474. PubMed ID: 36714030
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Gao X; Liu Y; Hong S; Yang H; Guan B; Ma X
    J Integr Neurosci; 2023 Aug; 22(5):135. PubMed ID: 37735118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PLEKHA4 is a novel prognostic biomarker that reshapes the tumor microenvironment in lower-grade glioma.
    Zhi W; Wang Y; Jiang C; Gong Y; Chen Q; Mao X; Deng W; Zhao S
    Front Immunol; 2023; 14():1128244. PubMed ID: 37818357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The Cancer Genome Atlas Data.
    Zhong J; Xiang D; Ma X
    Biomed Res Int; 2022; 2022():2309339. PubMed ID: 35845958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Zhao S; Li Y; Xu J; Shen L
    Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PLEKHA4 promotes glioblastoma progression through apoptosis inhibition, tumor cell migration, and macrophage infiltration.
    He Y; Zheng W; Huo Y; Sa L; Zhang H; He G; Shang P
    Immunobiology; 2023 Nov; 228(6):152746. PubMed ID: 37980830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetraspanins predict the prognosis and characterize the tumor immune microenvironment of glioblastoma.
    Li YC; Wu Y; Chen G; Zhu LZ; Luo X; Nie QQ; Zhang L; Zuo CJ
    Sci Rep; 2023 Aug; 13(1):13317. PubMed ID: 37587203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLC10A3 Is a Prognostic Biomarker and Involved in Immune Infiltration and Programmed Cell Death in Lower Grade Glioma.
    Ma W; Mei P
    World Neurosurg; 2023 Oct; 178():e595-e640. PubMed ID: 37543196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FCGR2B as a prognostic and immune microenvironmental marker for gliomas based on transcriptomic analysis.
    Sun Z; Sun X; Yuan Y; Li H; Li X; Yao Z
    Medicine (Baltimore); 2023 Sep; 102(37):e35084. PubMed ID: 37713871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ARPC5 acts as a potential prognostic biomarker that is associated with cell proliferation, migration and immune infiltrate in gliomas.
    Ming Y; Luo C; Ji B; Cheng J
    BMC Cancer; 2023 Oct; 23(1):937. PubMed ID: 37789267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TREM1 as a novel prognostic biomarker and tumor immune microenvironment evaluator in glioma.
    Lu Q; Xie Y; Qi X; Yang S
    Medicine (Baltimore); 2023 Dec; 102(48):e36410. PubMed ID: 38050264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-associated fibroblast-associated gene IGFBP2 promotes glioma progression through induction of M2 macrophage polarization.
    Zhang X; Sun X; Guo C; Li J; Liang G
    Am J Physiol Cell Physiol; 2024 Jan; 326(1):C252-C268. PubMed ID: 37982173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNALI1 is a prognosis-related biomarker and correlates with immune infiltrates in low grade glioma.
    Lu Y; Chang P; Bian J; Zhu L
    Cancer Biomark; 2023; 38(3):393-407. PubMed ID: 37955080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated profiling identifies CACNG3 as a prognostic biomarker for patients with glioma.
    Shan E; Cao YN; Zhang Y; Chen W; Ren X; Zhu S; Xi X; Mu S; Ma M; Zhi T; Li X
    BMC Cancer; 2023 Sep; 23(1):846. PubMed ID: 37697240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Siglec15 is a prognostic indicator and a potential tumor-related macrophage regulator that is involved in the suppressive immunomicroenvironment in gliomas.
    Wang J; Xu L; Ding Q; Li X; Wang K; Xu S; Liu B
    Front Immunol; 2023; 14():1065062. PubMed ID: 37325664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PROS1 shapes the immune-suppressive tumor microenvironment and predicts poor prognosis in glioma.
    Wang J; Wu N; Feng X; Liang Y; Huang M; Li W; Hou L; Yin C
    Front Immunol; 2022; 13():1052692. PubMed ID: 36685506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of the prognostic and immunological signature of eight Tripartitemotif (TRIM) family molecules in human gliomas.
    Lu J; Liang K; Zou R; Peng Y; Wang H; Huang R; Zeng Z; Feng Z; Fan Y; Zhang S; Ji Y; Pang X; Wang Y; Zhang H; Wang Z
    Aging (Albany NY); 2023 Jun; 15(12):5798-5825. PubMed ID: 37367937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggrephagy-related gene signature correlates with survival and tumor-associated macrophages in glioma: Insights from single-cell and bulk RNA sequencing.
    Zhang X; Tan J; Zhang X; Pandey K; Zhong Y; Wu G; He K
    Math Biosci Eng; 2024 Jan; 21(2):2407-2431. PubMed ID: 38454689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HOXD9 is a potential prognostic biomarker involved in immune microenvironment of glioma.
    Xu S; Xiao H; Song T; Zeng Y; Wei C; Chen T; Hu Z; Guo R; Li D; Jiang M
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14911-14926. PubMed ID: 37603105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lactate-induced up-regulation of PLEKHA4 promotes proliferation and apoptosis of human glioma cells].
    Ye J; Xu W; Xi B; Wang N; Chen T
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jul; 43(7):1071-1080. PubMed ID: 37488789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.